PEDIATRICS Vol. 70 No. 5 November 1982, pp. 824
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auerbach, A. D.
Right arrow Articles by Schroeder, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auerbach, A. D.
Right arrow Articles by Schroeder, T. M.

First Announcement of the Fanconi Anemia International Registry

Arleen D. Auerbach PhD1 and Traute M. Schroeder 2

1 Laboratory for Investigative Dermatology, The Rockefeller University, 1230 York Ave, New York, NY 10021
2 Institute of Human Genetics, University of Heidelberg, Im Neuenheimer Feld 328, 6900 Heidelberg, West Germany

We, Arleen D. Auerbach, USA, and Traute M. Schroeder, West Germany, call upon our colleagues to cooperate with us in order to establish and maintain an International Registry of all known Fanconi anemia (FA) patients. Clinical diagnosis of FA is often difficult to establish due to phenotypic diversity of patients and the occurrence of other disorders that manifest some of the features of FA. Diagnosis may be confirmed by the use of a cytogenetic method based on the sensitivity of FA lymphocytes, fibroblasts, and amniotic fluid cells to chemically induced chromosome breakage (Auerbach, Adler, and Chaganti: Pediatrics 67:128, 1981).